Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Receivables (2016 - 2025)

National Research's Receivables history spans 16 years, with the latest figure at $11.2 million for Q4 2025.

  • For Q4 2025, Receivables changed 0.0% year-over-year to $11.2 million; the TTM value through Dec 2025 reached $11.2 million, changed 0.0%, while the annual FY2025 figure was $11.2 million, 0.0% changed from the prior year.
  • Receivables for Q4 2025 was $11.2 million at National Research, down from $12.9 million in the prior quarter.
  • Across five years, Receivables topped out at $16.4 million in Q3 2021 and bottomed at $10.1 million in Q2 2024.
  • The 5-year median for Receivables is $13.0 million (2022), against an average of $13.2 million.
  • The largest annual shift saw Receivables fell 28.47% in 2021 before it increased 23.99% in 2025.
  • A 5-year view of Receivables shows it stood at $13.8 million in 2021, then rose by 5.32% to $14.6 million in 2022, then decreased by 14.43% to $12.5 million in 2023, then dropped by 9.81% to $11.2 million in 2024, then changed by 0.0% to $11.2 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Receivables are $11.2 million (Q4 2025), $12.9 million (Q3 2025), and $12.5 million (Q2 2025).